Tokyo - Delayed Quote JPY

Olympus Corporation (7733.T)

Compare
2,290.00
-10.00
(-0.43%)
At close: January 17 at 3:30:00 PM GMT+9

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Yasuo Takeuchi Representative Executive Officer, ESG Officer & Executive Chairman 497M -- 1957
Mr. Andre Roggan Executive Officer & CTO 462M -- 1962
Mr. Tetsuo Kobayashi Executive Officer and Chief Manufacturing & Supply Officer 119M -- 1960
Mr. Frank Drewalowski Executive Officer & Endoscopic Solutions Division Head 459M -- 1965
Ms. Gabriela Kaynor Executive Officer & Chief Strategy Officer 218M -- 1975
Tatsuya Izumi Executive Officer & CFO -- -- 1964
Stephen Kneebone Corporate Officer & Chief Information Officer 734M -- --
Mr. Takaaki Sakurai Vice President of Investor Relations -- -- --
Mr. Neil Boyden Tanner Executive Officer & Global General Counsel -- -- 1971
Shigeto Ohtsuki Executive Officer & Chief Human Resources Officer -- -- 1961

Olympus Corporation

Shinjuku Monolith
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
Tokyo, 163-0914
Japan
81 3 3340 2111 https://www.olympus-global.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
28,838

Description

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

Corporate Governance

Olympus Corporation’s ISS Governance QualityScore as of January 1, 2025 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 5; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 14, 2025 at 6:00 AM UTC

Olympus Corporation Earnings Date

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

November 8, 2024 at 10:59 AM UTC

Q2 2025 Earnings Presentation

Related Tickers